HRTX FY 2022 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$162M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$108M+24.7% YoY

Gross Profit

$53M49.0% margin

Operating Income

-$175M-162.2% margin

Net Income

-$182M-169.1% margin

EPS (Diluted)

$-1.67

Cash Flow

Operating Cash Flow

-$147M

Free Cash Flow

-$149M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$251M

Total Liabilities

$237M

Stockholders' Equity

$14M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$108M	$86M	+24.7%
Gross Profit	$53M	$40M	+30.9%
Operating Income	-$175M	-$218M	+19.8%
Net Income	-$182M	-$221M	+17.5%